Trial
NCT02475369
Pancreatic Enzyme Supplementation for Celiac Disease
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Actavis Inc.
Condition
Celiac Disease
Intervention
pancrelipase
Why stopped
The trial was terminated prematurely by the sponsor for administrative reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-12